Longitudinal amyloid cognitive composite in preclinical Alzheimer's disease.
Young Ju KimAlice HahnYu Hyun ParkDuk L NaJuhee ChinSang Won SeoPublished in: European journal of neurology (2022)
The LACPA may contribute to reduction in time and financial burden when monitoring Aβ-related cognitive decline and therapeutic efficacy of the disease-modifying agents specifically targeting Aβ in secondary prevention trials.